Association Between Prehospital Blood Glucose Levels and Outcomes in Patients With COVID-19 Infection: A Retrospective Cohort Study

Abstract

Background Hyperglycaemia is associated with worse outcomes in many settings. However, the association between dysglycaemia and adverse outcomes remains debated in COVID-19 patients. This study determined the association of prehospital blood glucose levels with acute medical unit (intensive care unit or high dependency unit) admission and mortality among COVID-19-infected patients.

Methods This was a single-centre, retrospective cohort study based on patients cared for by the prehospital medical mobile unit from a Swiss university hospital between March 2020 and April 2021. All adult patients with confirmed or suspected COVID-19 infection during the study period were included. Data were obtained from the prehospital medical files. The main exposure was prehospital blood glucose level. A 7.8 mmol/L cut-off was used to define high blood glucose level. Restricted cubic splines were also used to analyse the exposure as a continuous variable. The primary endpoint was acute medical unit admission; secondary endpoints were 7-day and 30-day mortality. Multivariable logistic regressions were performed to compute odds ratios.

Results A total of 276 patients were included. The mean prehospital blood glucose level was 8.8 mmol/l, and 123 patients presented high blood glucose levels. The overall acute medical unit admission rate was 31.2%, with no statistically significant difference according to prehospital blood glucose levels. The mortality rate was 13.8% at 7 days and 25% at 30 days. The 30-day mortality rate was higher in patients with high prehospital blood glucose levels, with an adjusted odds ratio of 2.5 (1.3–4.8).

Conclusions In patients with acute COVID-19 infection, prehospital blood glucose levels do not seem to be associated with acute medical unit admission. However, there was an increased risk of 30-day mortality in COVID-19 patients who presented high prehospital blood glucose levels.

Key words

prehospital care - emergency medical services - medical mobile units - covid-19 - blood glucose - diabetes - patient disposition

Publication History

Received: 17 January 2023
Received: 16 February 2023

Accepted: 17 February 2023

Accepted Manuscript online:
04 April 2023

Article published online:
22 May 2023

• References

• 1 Bouillon-Minois JB, Raconnat J, Clinchamps M. et al. Emergency department and overcrowding during COVID-19 outbreak; a letter to editor. Arch Acad Emerg Med 2021; 9: e28 DOI: 10.22037/aaem.v9i1.1167.
• 2 Zhou Y, Yang Q, Chi J. et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis 2020; 99: 47-56 DOI: 10.1016/j.ijid.2020.07.029.
• 3 Biswas M, Rahaman S, Biswas TK. et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: A systematic review and meta-analysis. Intervirology 2020; 1-12 DOI: 10.1159/000512592.
• 4 Petrakis V, Panagopoulos P, Trypsianis G. et al. Fasting plasma glucose increase and neutrophil to lymphocyte ratio (NLR) as risk predictors of clinical outcome of COVID-19 pneumonia in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2023; DOI: 10.1055/a-2009-6937.
• 5 Petrakis V, Panagopoulos P, Papazoglou D. et al. Diabetes mellitus and hypertension as major risk factors of mortality from Covid-19 pneumonia. Exp Clin Endocrinol Diabetes 2022; 130: 205-206 DOI: 10.1055/a-1325-0381.
• 6 Petrakis V, Panagopoulos P, Trypsianis G. et al. Glucose on admission: Unfavourable effects on hospitalisation and outcomes in type 2 diabetes mellitus patients with COVID-19 pneumonia. Exp Clin Endocrinol Diabetes 2022; 130: 561-562 DOI: 10.1055/a-1686-8738.
• 7 Marik PE, Bellomo R. Stress hyperglycemia: An essential survival response!. Crit Care 2013; 17: 305 DOI: 10.1186/cc12514.
• 8 Ishihara M. Acute hyperglycemia in patients with acute myocardial infarction. Circ J 2012; 76: 563-571 DOI: 10.1253/circj.cj-11-1376.
• 9 Cariou B, Hadjadj S, Wargny M. et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: The CORONADO study. Diabetologia 2020; 63: 1500-1515 DOI: 10.1007/s00125-020-05180-x.
• 10 Mirani M, Favacchio G, Carrone F. et al. Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: A case series from an Academic Hospital in Lombardy, Italy. Diabetes Care 2020; 43: 3042-3049 DOI: 10.2337/dc20-1340.
• 11 von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349 DOI: 10.1016/j.jclinepi.2007.11.008.
• 12 Chan M, Fehlmann CA, Pasquier M. et al. Endotracheal intubation success rate in an urban, supervised, resident-staffed emergency mobile system: An 11-year retrospective cohort study. J Clin Med 2020; 9 DOI: 10.3390/jcm9010238.
• 13 American Diabetes Association Professional Practice C. 16. Diabetes care in the hospital: Standards of medical care in diabetes-2022. Diabetes Care 2022; 45: S244-S253 DOI: 10.2337/dc22-S016.
• 14 Gaudet-Blavignac C, Ehrsam J, Turbe H. et al. Deep SNOMED CT enabled large clinical database about COVID-19. Stud Health Technol Inform 2022; 294: 317-321 DOI: 10.3233/SHTI220466.
• 15 Sardu C, D’Onofrio N, Balestrieri ML. et al. Outcomes in patients with hyperglycemia affected by COVID-19: Can we do more on glycemic control?. Diabetes Care 2020; 43: 1408-1415 DOI: 10.2337/dc20-0723.
• 16 Martinez-Murillo C, Ramos Penafiel C, Basurto L. et al. COVID-19 in a country with a very high prevalence of diabetes: The impact of admission hyperglycaemia on mortality. Endocrinol Diabetes Metab 2021; 4: e00279 DOI: 10.1002/edm2.279.
• 17 Bode B, Garrett V, Messler J. et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 2020; 14: 813-821 DOI: 10.1177/1932296820924469.
• 18 Delamaire M, Maugendre D, Moreno M. et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29-34 DOI: 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V.
• 19 Jafar N, Edriss H, Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci 2016; 351: 201-211 DOI: 10.1016/j.amjms.2015.11.011.
• 20 Martinez N, Vallerskog T, West K. et al. Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia. J Immunol 2014; 193: 4457-4468 DOI: 10.4049/jimmunol.1401125.
• 21 Schuetz P, Castro P, Shapiro NI. Diabetes and sepsis: Preclinical findings and clinical relevance. Diabetes Care 2011; 34: 771-778 DOI: 10.2337/dc10-1185.
• 22 Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res 2020; 51: 384-387 DOI: 10.1016/j.arcmed.2020.04.019.
• 23 Lim S, Bae JH, Kwon HS. et al. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat Rev Endocrinol 2021; 17: 11-30 DOI: 10.1038/s41574-020-00435-4.
• 24 Lapar DJ, Hajzus VA, Zhao Y. et al. Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling. Am J Respir Cell Mol Biol 2012; 46: 299-305 DOI: 10.1165/rcmb.2011-0247OC.
• 25 Capes SE, Hunt D, Malmberg K. et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773-778 DOI: 10.1016/S0140-6736(99)08415-9.
• 26 Stoudt K, Chawla S. Don’t sugar coat it: Glycemic control in the intensive care unit. J Intensive Care Med 2019; 34: 889-896 DOI: 10.1177/0885066618801748.
• 27 Kreutziger J, Lederer W, Schmid S. et al. Blood glucose concentrations in prehospital trauma patients with traumatic shock: A retrospective analysis. Eur J Anaesthesiol 2018; 35: 33-42 DOI: 10.1097/EJA.0000000000000733.
• 28 Abramson TM, Bosson N, Whitfield D. et al. Elevated prehospital point-of-care glucose is associated with worse neurologic outcome after out-of-hospital cardiac arrest. Resusc Plus 2022; 9: 100204 DOI: 10.1016/j.resplu.2022.100204.
• 29 Vihonen H, Laaperi M, Kuisma M. et al. Glucose as an additional parameter to National Early Warning Score (NEWS) in prehospital setting enhances identification of patients at risk of death: An observational cohort study. Emerg Med J 2020; 37: 286-292 DOI: 10.1136/emermed-2018-208309.
• 30 Midez R, Fehlmann CA, Marti C. et al. Association between prehospital hypoxemia and admission to intensive care unit during the COVID-19 pandemic: A retrospective cohort study. Medicina (Kaunas) 2021; 57 DOI: 10.3390/medicina57121362.
• 31 Jouffroy R, Lemoine S, Derkenne C. et al. Prehospital management of acute respiratory distress in suspected COVID-19 patients. Am J Emerg Med 2021; 45: 410-414 DOI: 10.1016/j.ajem.2020.09.022.
• 32 Zhu Z, Zeng Q, Liu Q. et al. Association of glucose-lowering drugs with outcomes in patients with diabetes before hospitalization for COVID-19: A systematic review and network meta-analysis. JAMA Netw Open 2022; 5: e2244652 DOI: 10.1001/jamanetworkopen.2022.44652.
• 33 Tay MZ, Poh CM, Renia L. et al. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol 2020; 20: 363-374 DOI: 10.1038/s41577-020-0311-8.
• 34 Yamasaki Y, Ooka S, Matsuoka S. et al. Predicting the aggravation of coronavirus disease-19 pneumonia using chest computed tomography scans. PLoS One 2022; 17: e0276738 DOI: 10.1371/journal.pone.0276738.
• 35 Costantini E, Carlin M, Porta M. et al. Type 2 diabetes mellitus and sepsis: State of the art, certainties and missing evidence. Acta Diabetol 2021; 58: 1139-1151 DOI: 10.1007/s00592-021-01728-4.